Literature DB >> 29853513

Complete Genome Sequence of a Lumpy Skin Disease Virus Strain Isolated from the Skin of a Vaccinated Animal.

Ivana Lojkić1, Ivana Šimić2, Nina Krešić2, Tomislav Bedeković2.   

Abstract

Vaccination of cattle against lumpy skin disease (LSD) can cause adverse reactions. Here, we report the first complete genome sequence of an LSD virus strain isolated from the skin of a vaccinated animal. We confirmed that the sequence of the virus used for vaccination remains stable.
Copyright © 2018 Lojkić et al.

Entities:  

Year:  2018        PMID: 29853513      PMCID: PMC5981036          DOI: 10.1128/genomeA.00482-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

In 2015, lumpy skin disease was recorded for the first time in Greece and Cyprus, and since 2016, lumpy skin disease virus (LSDV) has been rapidly spreading to neighboring countries (Bulgaria, Macedonia, Serbia, Kosovo, Montenegro, and Albania) (1). In Croatia, the preventive vaccination program against lumpy skin disease targeting the entire cattle population was approved by the European Commission (2). Adverse reactions to vaccination, which include the formation of generalized skin nodules accompanied by the detection of vaccine virus in blood, saliva, skin, and milk, were recorded (3). Here, we report the complete genome sequence of an LSDV strain isolated from the skin of a vaccinated animal showing generalized skin nodules (CRO2016). Cattle were vaccinated with Lumpyvax (104 50% tissue culture infective dose [TCID50]/ml live, attenuated SIS type virus; MSD Intervet South Africa [Pty] Ltd., Spartan, RSA), according to the manufacturer’s recommendations. The virus was isolated from a biopsy specimen of a skin nodule sampled away from the vaccine injection site and passaged eight times on Madin-Darby bovine kidney (MDBK) cells, as described before (3). The complete genome was determined by next-generation sequencing (NGS) using Illumina technology. Total DNA was extracted using the DNeasy blood and tissue kit (Qiagen, Hilden, Germany), according to the manufacturer’s instructions. A sequencing library was constructed using the Nextera XT DNA library preparation kit and sequenced using a MiSeq reagent kit version 2 with 2 × 250-bp paired-end sequencing on a MiSeq benchtop sequencer (Illumina). For genome assembly, a total of 74,945 reads were mapped to the reference genome (GenBank accession number KX764643) using the Geneious software R10 (Biomatters Ltd., Auckland, New Zealand). After manual inspection of the genome reference mapping, no discrepancies were found. Open reading frames were predicted with the Genome Annotation Transfer Utility (GATU) (4) relative to the LSDV vaccine strain Lumpyvax sequence (GenBank accession number KX764643). The obtained genome sequence (150,448 bp) was 100% identical to that of the vaccine virus (GenBank accession number KX764643). This confirms that vaccine virus can be isolated from the skin of a vaccinated animal and passaged eight times in MDBK cells, with no effect on sequence composition and thus on the nature of the vaccine virus itself.

Accession number(s).

The complete genome sequence of the isolate CRO2016 has been deposited in GenBank under accession number MG972412.
  2 in total

1.  Detection of lumpy skin disease virus in skin lesions, blood, nasal swabs and milk following preventive vaccination.

Authors:  T Bedeković; I Šimić; N Krešić; I Lojkić
Journal:  Transbound Emerg Dis       Date:  2017-10-30       Impact factor: 5.005

2.  Genome Annotation Transfer Utility (GATU): rapid annotation of viral genomes using a closely related reference genome.

Authors:  Vasily Tcherepanov; Angelika Ehlers; Chris Upton
Journal:  BMC Genomics       Date:  2006-06-13       Impact factor: 3.969

  2 in total
  8 in total

1.  Molecular characterization of lumpy skin disease virus in Iran (2014-2018).

Authors:  Zeinab Hedayati; Hamid Reza Varshovi; Ali Mohammadi; Mohammad Tabatabaei
Journal:  Arch Virol       Date:  2021-05-31       Impact factor: 2.574

2.  Phylogenomic characterization of historic lumpy skin disease virus isolates from South Africa.

Authors:  Antoinette van Schalkwyk; Pravesh Kara; Livio Heath
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685

3.  An in-depth bioinformatic analysis of the novel recombinant lumpy skin disease virus strains: from unique patterns to established lineage.

Authors:  Alena Krotova; Olga Byadovskaya; Irina Shumilova; Antoinette van Schalkwyk; Alexander Sprygin
Journal:  BMC Genomics       Date:  2022-05-24       Impact factor: 4.547

4.  Isolation and characterization of lumpy skin disease virus from cattle in India.

Authors:  Naveen Kumar; Yogesh Chander; Ram Kumar; Nitin Khandelwal; Thachamvally Riyesh; Khushboo Chaudhary; Karuppusamy Shanmugasundaram; Sanjit Kumar; Anand Kumar; Madhurendu K Gupta; Yash Pal; Sanjay Barua; Bhupendra N Tripathi
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

5.  Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.

Authors:  Matome Selina Matsiela; Leeann Naicker; Vusi Saul Dibakwane; Nomfundo Ntombela; Thandeka Khoza; Nobalanda Mokoena
Journal:  Vaccine X       Date:  2022-08-18

6.  Genetic Evidence of Multiple Introductions of Lumpy Skin Disease Virus into Saratov Region, Russia.

Authors:  Yuri V Saltykov; Anna A Kolosova; Nadezhda N Filonova; Alexander N Chichkin; Valentina A Feodorova
Journal:  Pathogens       Date:  2021-06-07

7.  Investigation of Post Vaccination Reactions of Two Live Attenuated Vaccines against Lumpy Skin Disease of Cattle.

Authors:  Zahra Bamouh; Jihane Hamdi; Siham Fellahi; Slimane Khayi; Mohammed Jazouli; Khalid Omari Tadlaoui; Ouafaa Fassi Fihri; Eeva Tuppurainen; Mehdi Elharrak
Journal:  Vaccines (Basel)       Date:  2021-06-08

8.  Potential link of single nucleotide polymorphisms to virulence of vaccine-associated field strains of lumpy skin disease virus in South Africa.

Authors:  Antoinette van Schalkwyk; Pravesh Kara; Karen Ebersohn; Arshad Mather; Cornelius Henry Annandale; Estelle Hildegard Venter; David Brian Wallace
Journal:  Transbound Emerg Dis       Date:  2020-09-02       Impact factor: 4.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.